Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9206209
APP PUB NO 20130316970A1
SERIAL NO

13879709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An exemplary emboidment is related to a pharmaceutical composition of the class of nucleotide analogues and antiviral pro-nucleotides useful in partial or complete inhibition of human immunodeficiency virus (HIV). An exemplary embodiment is expressed in the formula (XVI):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTYTUT CHEMII BIOORGANICZNEJ PAN61-704 POZNAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boryski, Jerzy Poznan, PL 1 0
Kraszewski, Adam Poznan, PL 1 0
Lipniacki, Andrzej Warsaw, PL 2 0
Piasek, Andrzej Warsaw, PL 2 0
Romanowska, Joanna Lubon, PL 2 1
Sobkowski, Michal Poznan, PL 1 0
Stawinski, Jacek Poznan, PL 1 0
Szymanska-Michalak, Agnieszka Sroda Wlkp, PL 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00